Skip to main content
. 2020 Dec 19;130:104186. doi: 10.1016/j.compbiomed.2020.104186

Fig. 4.

Fig. 4

Binding of potential drugs (A) telaprevir, (B) ceftaroline fosamil, (C) atorvastatin, (D) clofazimine, (E) sildenafil, (F) everolimus, and (G) remikiren with the SARS-CoV-2 Mpro active site during 50 ns simulations.